Search Results 2081-2090 of 16885 for Gram-negative

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Harnessing the power of viruses to treat noninvasive breast cancer, triple-negative breast cancer and metastatic breast cancer. Innovative breast imaging ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Harnessing the power of viruses to treat noninvasive breast cancer, triple-negative breast cancer and metastatic breast cancer. Innovative breast imaging ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Harnessing the power of viruses to treat noninvasive breast cancer, triple-negative breast cancer and metastatic breast cancer. Innovative breast imaging ...

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Harnessing the power of viruses to treat noninvasive breast cancer, triple-negative breast cancer and metastatic breast cancer. Innovative breast imaging ...

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Harnessing the power of viruses to treat noninvasive breast cancer, triple-negative breast cancer and metastatic breast cancer. Innovative breast imaging ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Harnessing the power of viruses to treat noninvasive breast cancer, triple-negative breast cancer and metastatic breast cancer. Innovative breast imaging ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Harnessing the power of viruses to treat noninvasive breast cancer, triple-negative breast cancer and metastatic breast cancer. Innovative breast imaging ...

  8. Clinical trials - Oncology (Medical)

    Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer. Rochester, Minn. This ...

  9. Breast cancer - Doctors and departments - Mayo Clinic

    Harnessing the power of viruses to treat noninvasive breast cancer, triple-negative breast cancer and metastatic breast cancer. Innovative breast imaging ...

  10. A Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination with Rituximab in Participants With Refractory Large B-Cell Lymphoma (ZUMA-14) - Mayo Clinic

    Known CD19 negative or CD20 negative tumor. History of Richter's transformation of CLL. Prior CAR therapy or other genetically modified T-cell therapy ...